RENs/RENt analogs (NABI)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameRENs/RENt analogs (NABI)
Drug Alias Namecancer therapy (NABI)HCV therapy (NABI)HSV therapy (NABI)HIV therapy (NABI)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsNeoplasmsHepatitis CHerpes Simplex +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Maryland
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of MarylandVaxart Inc
Active IndicationsN/A
Inactive IndicationsNeoplasmsHepatitis CHerpes Simplex +[4] 

Other Information

ATC CodeN/A
Related LinksN/A